Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Braveheart Bio, Inc. - Common Stock (NQ:BRVE)

18.71 -0.84 (-4.30%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 414,852
Open 19.50
Bid (Size) 18.53 (100)
Ask (Size) 18.71 (200)
Prev. Close 19.55
Today's Range 18.00 - 19.59
52wk Range 17.86 - 32.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
From Braveheart Bio, Inc.
Via GlobeNewswire
News headline image
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
From Braveheart Bio, Inc.
Via GlobeNewswire

Performance

52-Week Range 41.5% below 52-week high
18.71
17.8652W Low 32.0052W High
1 Week 10.0% below 1-week high
18.431W Low 20.781W High

Braveheart Bio, Inc. - Common Stock (BRVE) traded between $17.86 and $32.00 over the past 52 weeks and last traded at $18.71, 41.5% below its 52-week high. Over the past week it ranged between $18.43 and $20.78.

Past 12 Months
-6.5%
-30.0%
-37.2%
-37.2%
-37.2%
-37.2%
1W -$1.31
1M -$8.00
3M -$11.09
6M -$11.09
YTD -$11.09
1Y -$11.09

BRVE was -37.2% over the past year, -37.2% over six months, -37.2% year to date, -6.5% in the last week.

12 Months vs Market
BRVE
-37.2%
DIA
+12.2%
SPY
+14.7%
QQQ
+17.9%
IWM
+8.0%

Over the past 12 months BRVE returned -37.2% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.7%, QQQ (Nasdaq 100) +17.9% and IWM (Russell 2000) +8.0%.

Volume & Liquidity 0.79× 3-mo avg
Today 414,852 3-mo avg 528.4K
1W
258.3K
1M
605.1K
3M
528.4K
6M
528.4K
YTD
528.4K
1Y
528.4K

BRVE most recently traded 414,852 shares against a 3-month average daily volume of 528.4K.

More News

Read More
News headline image
Braveheart Bio to Participate in Cantor Global Healthcare Conference
From Braveheart Bio, Inc.
Via GlobeNewswire
News headline image
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
Via MarketBeat
Topics Initial Public Offering
News headline image
Braveheart Bio CFO Acquires 27,777 Shares for $500,000. Is This a Signal BRVE IPO Is a Success? ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Braveheart Bio Chairman Chris Viehbacher Buys $1.5M Shares at IPO. What Does This Mean for Investors? ↗
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Braveheart Bio CEO Travis Murdoch Buys 83,333 Shares for $1.5 Million. Is This a Buy Signal for Investors? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Braveheart Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Braveheart Bio, Inc. - Common Stock publicly traded?
Yes, Braveheart Bio, Inc. - Common Stock is publicly traded.
What exchange does Braveheart Bio, Inc. - Common Stock trade on?
Braveheart Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Braveheart Bio, Inc. - Common Stock?
The ticker symbol for Braveheart Bio, Inc. - Common Stock is BRVE on the Nasdaq Stock Market
What is the current price of Braveheart Bio, Inc. - Common Stock?
The current price of Braveheart Bio, Inc. - Common Stock is 18.71
When was Braveheart Bio, Inc. - Common Stock last traded?
The last trade of Braveheart Bio, Inc. - Common Stock was at 10/16/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.